Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New approaches to triglyceride reduction: Is there any hope left?
Filtz A, Parihar S, Greenberg GS, Park CM, Scotti A, Lorenzatti D, Badimon JJ, Soffer DE, Toth PP, Lavie CJ, Bittner V, Virani SS, Slipczuk L. Filtz A, et al. Among authors: badimon jj. Am J Prev Cardiol. 2024 Mar 22;18:100648. doi: 10.1016/j.ajpc.2024.100648. eCollection 2024 Jun. Am J Prev Cardiol. 2024. PMID: 38584606 Free PMC article.
Dual SGLT1 and SGLT2 inhibition: more than the sum of its parts.
Sánchez-Muñoz E, Requena-Ibáñez JA, Badimón JJ. Sánchez-Muñoz E, et al. Among authors: badimon jj. Rev Esp Cardiol (Engl Ed). 2024 Jul;77(7):510-514. doi: 10.1016/j.rec.2024.01.011. Epub 2024 Mar 22. Rev Esp Cardiol (Engl Ed). 2024. PMID: 38521442 English, Spanish. No abstract available.
Does One Size Fits All?
Roldan V, Badimon JJ. Roldan V, et al. Among authors: badimon jj. Cardiovasc Drugs Ther. 2024 Sep 5. doi: 10.1007/s10557-024-07625-6. Online ahead of print. Cardiovasc Drugs Ther. 2024. PMID: 39235567 No abstract available.
Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure.
Angermann CE, Santos-Gallego CG, Requena-Ibanez JA, Sehner S, Zeller T, Gerhardt LMS, Maack C, Sanz J, Frantz S, Fuster V, Ertl G, Badimon JJ. Angermann CE, et al. Among authors: badimon jj. Nat Cardiovasc Res. 2023 Nov;2(11):1032-1043. doi: 10.1038/s44161-023-00352-5. Epub 2023 Oct 26. Nat Cardiovasc Res. 2023. PMID: 39196095 Free PMC article. Clinical Trial.
Antithrombotic and prohemorrhagic actions of different concentrations of apixaban in patients exposed to single and dual antiplatelet regimens.
Martinez-Sanchez J, Castrillo L, Jerez D, Torramade-Moix S, Palomo M, Mendieta G, Zafar MU, Moreno-Castaño AB, Sanchez P, Badimon JJ, Diaz-Ricart M, Escolar G, Roqué M. Martinez-Sanchez J, et al. Among authors: badimon jj. Sci Rep. 2023 Dec 27;13(1):22969. doi: 10.1038/s41598-023-50347-2. Sci Rep. 2023. PMID: 38151494 Free PMC article.
The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events.
Cordero A, Fernández Olmo R, Badimon L, Santos-Gallego CG, Castellano JM, Fácila L, Rodriguez-Manero M, Bonanad C, Vilahur G, Escribano D, Badimon JJ, González-Juanatey JR. Cordero A, et al. Among authors: badimon jj. J Clin Lipidol. 2023 Sep-Oct;17(5):602-611. doi: 10.1016/j.jacl.2023.08.006. Epub 2023 Aug 22. J Clin Lipidol. 2023. PMID: 37775463
Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials.
Cordero A, Fernandez Olmo R, Santos-Gallego CG, Fácila L, Bonanad C, Castellano JM, Rodriguez-Mañero M, Seijas-Amigo J, González-Juanatey JR, Badimon JJ. Cordero A, et al. Among authors: badimon jj. Am J Cardiol. 2023 Oct 15;205:321-324. doi: 10.1016/j.amjcard.2023.07.145. Epub 2023 Aug 25. Am J Cardiol. 2023. PMID: 37633067
378 results